Efficacy and safety of istradefylline in moderate to severe Parkinson’s disease: A phase 3, multinational, randomized, double-blind, placebo-controlled trial (i-step study): Abstracts from the World Congress of Neurology (WCN 2017)

S. Isaacson, K. Eggert, R. Kumar, F. Stocchi, A. Mori, E. Ohta, K. Toyama, G. Spence, G. Clark, M. Cantillon

Research output: Contribution to journalMeeting Abstract

Original languageEnglish
Pages (from-to)351-352
Number of pages2
JournalJournal of the Neurological Sciences
Publication statusPublished - 2017

Cite this